U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07278375) titled 'Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome' on Nov. 21.
Brief Summary: The goal of this observational study is to learn how two medicines used in routine care-buprenorphine and morphine-affect recovery in newborns (>=36 weeks' gestation) with Neonatal Opioid Withdrawal Syndrome (NOWS). The main questions it aims to answer are:
1. Do infants treated with buprenorphine become medically ready for discharge sooner than those treated with morphine?
2. Does one treatment lead to better overall clinical outcomes than the other?
Researchers will compare infants who received buprenorphine wit...